Aerosol formulations and aerosol delivery of scopolamine

Details Aerosol formulations and aerosol delivery of scopolamine Aerosol formulations and aerosol delivery of scopolamine

2004-10-06

2008-08-12

Haghighatian, Mina (Department: 1616)

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

C514S958000, C128S200140, C128S203120, C128S203160

Reexamination Certificate

active

07410635

ABSTRACT:
A liquid aerosol formulation comprising at least one thermally stable active ingredient selected from the group consisting of butalbital, lorazepam, ipratropium, baclofen, morphine, scopolamine, pharmaceutically acceptable salts and esters thereof and derivatives thereof. The liquid formulation can include an organic solvent such as propylene glycol and one or more optional excipients. The active ingredient can be present in an amount of 0.01 to 5 weight percent and the formulation can be heated to provide a vapor which forms an aerosol having a mass median aerodynamic diameter of less than 3 μm.

REFERENCES:
patent: 5743251 (1998-04-01), Howell et al.
patent: 6234167 (2001-05-01), Cox et al.
patent: 6501052 (2002-12-01), Cox et al.
patent: 6516796 (2003-02-01), Cox et al.
patent: 6557552 (2003-05-01), Cox et al.
patent: 6568390 (2003-05-01), Nichols et al.
patent: 6640050 (2003-10-01), Nichols et al.
patent: 6682716 (2004-01-01), Hodges et al.
patent: 6701922 (2004-03-01), Hindle et al.
patent: 6766220 (2004-07-01), McRae et al.
patent: 6799572 (2004-10-01), Nichols et al.
patent: 6854461 (2005-02-01), Nichols et al.
patent: 6883516 (2005-04-01), Hindle et al.
patent: 6923179 (2005-08-01), Gupta et al.
patent: 7040314 (2006-05-01), Nguyen et al.
patent: 7077130 (2006-07-01), Nichols et al.
patent: 7117867 (2006-10-01), Cox et al.
patent: 7128067 (2006-10-01), Byron et al.
patent: 7147170 (2006-12-01), Nguyen et al.
patent: 7163014 (2007-01-01), Nichols et al.
patent: 7167776 (2007-01-01), Maharajh et al.
patent: 7173222 (2007-02-01), Cox et al.
patent: 2003/0106551 (2003-06-01), Sprinkel, Jr. et al.
patent: 2004/0009128 (2004-01-01), Rabinowitz et al.
patent: 2004/0016427 (2004-01-01), Byron et al.
patent: 2004/0079368 (2004-04-01), Gupta et al.
patent: 2004/0081624 (2004-04-01), Nguyen et al.
patent: 2004/0129793 (2004-07-01), Nguyen et al.
patent: 2004/0151670 (2004-08-01), Blondino et al.
patent: 2004/0170405 (2004-09-01), Sherwood et al.
patent: 2004/0223917 (2004-11-01), Hindle et al.
patent: 2004/0223918 (2004-11-01), Pham et al.
patent: 2005/0126624 (2005-06-01), Pellizzari
patent: 2005/0133029 (2005-06-01), Nichols et al.
patent: 2005/0143866 (2005-06-01), McRae et al.
patent: 2005/0205084 (2005-09-01), Gupta et al.
patent: 3926751 (1991-02-01), None
patent: 1177793 (2002-02-01), None
patent: WO 86/04233 (1986-07-01), None
patent: WO 99/16417 (1999-04-01), None
patent: WO 01/62227 (2001-08-01), None
patent: WO 01/81182 (2001-11-01), None
patent: WO 02/094237 (2002-11-01), None
International Search Report and Written Opinion dated Oct. 25, 2005 for PCT/US2004/032449.
International Preliminary Report on Patentability dated Apr. 10, 2006 for PCT/US2004/032449.

Affiliated with

Also associated with

Rating

Aerosol formulations and aerosol delivery of scopolamine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aerosol formulations and aerosol delivery of scopolamine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aerosol formulations and aerosol delivery of scopolamine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3996260